Advertisement

Topics

Why don’t we rely exclusively on CEA estimates to make drug coverage determinations?

23:47 EST 7 Nov 2017 | Healthcare Economist

Cost effectiveness analyses (CEA) typically analyses the value of a new treatment relative to its cost.  If the value of the additional health benefits outweigh the additional cost, then they should be covered; if the additional cost outweighs the additional benefit, then it should not be covered, right? There are a few issues with this […]

Original Article: Why don’t we rely exclusively on CEA estimates to make drug coverage determinations?

NEXT ARTICLE

More From BioPortfolio on "Why don’t we rely exclusively on CEA estimates to make drug coverage determinations?"

Advertisement
Quick Search
Advertisement
Advertisement